Romania‘s drug producer Biofarm announced on Tuesday that it has inaugurated a new production and testing facility in Bucharest following an investment of over €35mln, according to a press release.
Biofarm stated that with a usable area of over 10.000 sqm and an annual production flow three times higher than in the existing plant, the new Biofarm factory will ensure the production of a complex portfolio of pharmaceutical products.
“The new factory will have four production streams, coated tablets/tablets/drops, soft capsules, solutions, and syrups,” said Biofarm.
Biofarm general manager, Catalin Vicol stated that the new production unit is an important investment in the pharmaceutical industry for the last 30 years.
Biofarm is a manufacturer of soft gelatin capsules, among the top three Romanian manufacturers of solutions and suspensions for oral administration and one of the largest manufacturers of tablets and dragees in Romania.